Author | Christian Gisselbrecht, MD

Articles

Is Dose-Dense Therapy Effective Against DLBCL in the Era of Rituximab?

May 15, 2012

If there is one disease for which patients have experienced a significant improvement in the cure rate over the past 10 years, it is diffuse large B-cell lymphoma (DLBCL).